INSMED INC (INSM)       21.69  +0.23 (+1.07%)

21.69  +0.23 (+1.07%)

US4576693075 - Common Stock - After market: 21.69 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 41.43. This target is 91% above the current price.
INSM was analyzed by 19 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about INSM.
In the previous month the buy percentage consensus was at a similar level.
INSM was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 21.6928.2838.7641.4354.60 - 30.38% 78.70% 91.00% 151.73%

Up and Down Grades

Date Firm Action Rating
2023-01-20 Barclays Maintains Overweight
2023-01-09 Goldman Sachs Maintains Buy
2022-12-09 Mizuho Initiate Buy
2022-12-08 Barclays Initiate Overweight
2022-12-07 Barclays Initiate Overweight
2022-11-18 B of A Securities Initiate Buy
2022-10-27 SVB Leerink Maintains Outperform
2022-10-25 Cantor Fitzgerald Maintains Overweight
2022-10-21 Cowen & Co. Maintains Outperform
2022-07-15 Morgan Stanley Maintains Overweight
2022-05-24 Goldman Sachs Maintains Buy
2022-04-27 Goldman Sachs Initiate Buy
2022-02-22 SVB Leerink Maintains Outperform
2021-12-06 JP Morgan Initiate Overweight
2021-10-08 Cantor Fitzgerald Initiate Overweight
2021-05-10 Morgan Stanley Maintains Overweight
2021-03-02 Morgan Stanley Maintains Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA